ClinConnect ClinConnect Logo
Search / Trial NCT03477929

Cetrorelix and Ganirelix Flexible Protocol for (IVF)

Launched by UNIVERSITÀ DEGLI STUDI 'G. D'ANNUNZIO' CHIETI E PESCARA · Mar 19, 2018

Trial Information

Current as of June 03, 2025

Unknown status

Keywords

In Vitro Fertilization Gnrh Antagonist Pituitary Suppression

ClinConnect Summary

No description provided

Gender

FEMALE

Eligibility criteria

  • Inclusion criteria :
  • 18-39 hyears old with regular menstrual cycles (25-35 days in length);
  • Body Mass Index between 18-29 kg\\m2
  • Basal follicle-stimulating hormone levels within normal range (\<30 mUI\\mL)
  • Absence of clinically relevant anomalies at transvaginal ultrasound examinatio
  • Exclusion Criteria:
  • Patients affected by grade III or IV endometriosis according to American Society for Reproductive Medicine (ASRM)
  • History of Ovarian Hyperstimulation Stimulation (OHSS)
  • History of poor response in previous IVF\\ICSI cycle: ≤ 3 oocytes retrieved
  • ≥ 3 prior consecutive IVF\\ICSI cycle without a clinical pregnancy.

About Università Degli Studi 'G. D'annunzio' Chieti E Pescara

The Università degli Studi 'G. D'Annunzio' Chieti e Pescara is a prestigious academic institution in Italy, renowned for its commitment to advancing medical research and education. With a strong emphasis on interdisciplinary collaboration, the university actively engages in clinical trials that aim to enhance patient care and therapeutic outcomes. Its dedicated research teams leverage cutting-edge methodologies and innovative approaches to address pressing health challenges, contributing significantly to the scientific community and the development of novel medical interventions. Through its robust infrastructure and expertise, the university fosters an environment conducive to excellence in clinical research.

Locations

Ortona, Chieti, Italy

Patients applied

0 patients applied

Trial Officials

Gian Mario Tiboni, professor

Study Director

Università degli Studi 'G. d'Annunzio' Chieti e Pescara

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials